logo

ZTS

Zoetis·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ZTS fundamentals

Zoetis (ZTS) released its earnings on Nov 4, 2025: revenue was 2.40B (YoY 0.00%), missed estimates; EPS was 1.7 (YoY +7.59%), beat estimates.
Revenue / YoY
2.40B
0.00%
EPS / YoY
1.7
+7.59%
Report date
Nov 4, 2025
ZTS Earnings Call Summary for Q3,2025
  • Revenue Growth: 4% organic operational, driven by Companion Animal and Livestock.
  • Challenges: OA pain franchise down 11%, competitive dermatology pressure.
  • Innovation: 2026 launches of Lenivia and Portela to expand OA market.
  • Margins: Gross margin 71.6%, cost control maintained.
  • Guidance: 2025 organic 5.5-6.5%, 2026 focus on price, alternative channels.
EPS
Revenue

Revenue & Expenses

ZTS has released its 2025 Q3 earnings report, with revenue of 2.40B, reflecting a YoY change of 0.50%, and net profit of 721.00M, showing a YoY change of 4.19%. The Sankey diagram below clearly presents ZTS's revenue sources and cost distribution.

Key Indicators

Zoetis (ZTS) key financial stats and ratios, covering profitability, financial health, and leverage.
Zoetis (ZTS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Zoetis (ZTS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Zoetis (ZTS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Zoetis (ZTS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Zoetis (ZTS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield